Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 1.22 million during the last session, with the company’s beta value hitting -1.20. At the close of
In the last trading session, 1.77 million Candel Therapeutics Inc (NASDAQ:CADL) shares changed hands as the company’s beta touched -1.17. With the company’s per share
In the latest trading session, 0.64 million Candel Therapeutics Inc (NASDAQ:CADL) shares changed hands as the company’s beta touched -1.17. With the company’s most recent
In last trading session, Candel Therapeutics Inc (NASDAQ:CADL) saw 1.49 million shares changing hands with its beta currently measuring -1.19. Company’s recent per share price
Candel Therapeutics Inc (NASDAQ:CADL) has a beta value of -1.20 and has seen 1.38 million shares traded in the last trading session. The company, currently
Candel Therapeutics Inc (NASDAQ:CADL) has a beta value of -1.19 and has seen 1.97 million shares traded in the last trading session. The company, currently
During the last session, Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares were 1.24 million, with the beta value of the company hitting -1.12. At the end
In the last trading session, 2.07 million shares of the Candel Therapeutics Inc (NASDAQ:CADL) were traded, and its beta was -1.10. Most recently the company’s
In the last trading session, 2.24 million shares of the Candel Therapeutics Inc (NASDAQ:CADL) were traded, and its beta was -1.02. Most recently the company’s
Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 1.1 million during the last session, with the company’s beta value hitting -1.08. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
